Skip to main content

Codelivery of TGF-β1 and anti-miR-141 by PLGA microspheres inhibits progression of intervertebral disc degeneration

Abstract

Background

Cervical and lumbar pain is usually caused by degeneration of the nucleus pulposus (NP). As a powerful therapeutic strategy, tissue engineering can effectively restore the normal biological properties of the spinal unit. Previous studies suggested that poly(lactic-co-glycolic acid) (PLGA) microspheres are effective carriers of cells and biomolecules in NP tissue engineering. This study aims to explore the therapeutic effect of PLGA microspheres coloaded with transforming growth factor-β1 (TGF-β1) and anti-miR-141 on intervertebral disc degeneration (IDD).

Methods

PLGA microspheres were characterized by scanning electron microscopy, a laser particle size analyzer, and laser confocal microscopy. The in vitro release rate of biomolecules from the microspheres was analyzed by reversed-phase high-performance liquid chromatography and agarose gel electrophoresis. The rat NP cells (NPCs) treated with the solutions released from microspheres for different lengths of time were assigned to a control group (Ctrl), an empty PLGA microsphere group (Mock microsphere, MS), a TGF-β1-loaded PLGA microsphere group (TMS), an anti-miR-141-loaded PLGA microsphere group (AMS), and an anti-miR-141 + TGF-β1-loaded PLGA microsphere group (ATMS). The proliferation and apoptosis of NPCs were observed by alamar blue and flow cytometry. The gene and protein expression of cartilage markers COL2A1 and ACAN were observed by RT-qPCR and Western blot. The rat model of IDD was established by tail puncture. Rats were divided into a control group (Ctrl), a mock operation group (Mock), a TGF-β1 microsphere group (TMS), an anti-miR-141 microsphere group (AMS), and an anti-miR-141 + TGF-β1 microsphere group (ATMS). The degree of rat tail IDD was assessed in each group through magnetic resonance imaging (MRI), safranin O-fast green staining, immunohistochemistry, and Western blotting.

Results

PLGA microspheres were stably coloaded and could sustainably release TGF-β1 and anti-miR-141. The results of in vitro cell experiments showed that the release solution of PLGA microspheres significantly enhanced the proliferation of NPCs without inducing their apoptosis and significantly upregulated cartilage markers in NPCs. The effect of microspheres was greater in the ATMS group than that in the TMS group and AMS group. In vivo experiments showed that IDD could be effectively inhibited and reversed by adding microspheres coloaded with TGF-β1 and/or anti-miR-141, and the effect was greatest in the ATMS group.

Conclusion

PLGA microspheres coloaded with TGF-β1 and anti-miR-141 can reverse IDD by inhibiting the degeneration of NPCs.

Introduction

Cervical and lumbar pain, a common orthopedic disease, seriously affects the work and life of patients, and intervertebral disc degeneration (IDD) is considered the initiating factor for the occurrence and progression of cervical and lumbar pain [1, 2]. The intervertebral disc is composed of the annulus fibrosus, nucleus pulposus (NP), and cartilage endplates. NP degeneration is thought to be the earliest change of IDD as well as the most critical step in the IDD process [3, 4]. The NP can keep its homeostatic balance under normal circumstances. In the case of NP degeneration, such homeostasis is broken, thus causing pathological changes that mainly manifest as a decrease in NP cells (NPCs), loss of proteoglycan in the extracellular matrix, and disorders of collagen structure. Ultimately, dehydration, revascularization, and re-neuralization of NP occur, leading to loss of function and causing corresponding clinical symptoms [5, 6]. Therefore, exploring the degeneration and regenerative repair of NP tissues is the core of the IDD research field [7].

Due to the poor self-repair ability of NP tissues, IDD is rarely self-reversable. An ideal therapy could be to promote the secretion of extracellular matrix by NPCs and inhibit relevant catabolic enzymes through the actions of biological agents [8]. Transforming growth factor-β1 (TGF-β1) has a key regulatory role in IDD [9, 10]. Injecting TGF-β1 into the degenerated intervertebral disc can exert a definite repair effect on the intervertebral disc [11]. The in vivo use of TGF-β1 is restricted due to its easy degradation, short half-life, and difficulty of long-term stable expression [12].

miRNAs, a class of endogenous, non-coding, small RNA molecules, can regulate the stability and transcriptional expression of mRNAs. Abnormally expressed miRNAs are important regulators in the pathophysiological process of IDD [13]. Applying miRNAs to the repair in the field of regenerative medicine is becoming a new research hotspot [14,15,16,17,18]. However, miRNAs are also prone to degradation in vivo, so carriers are required for their efficient and safe transfection.

In recent years, growing attention has been paid to microparticle systems in tissue engineering. With excellent biocompatibility and a more uniform degradation rate, poly(lactic-co-glycolic acid) (PLGA) can meet different needs of tissue engineering if its composition ratio and molecular weight are adjusted [19]. In this study, injectable microspheres were constructed based on PLGA, and TGF-β1/anti-miR-141 complexes were loaded on PLGA microspheres for in situ delivery. The microspheres significantly inhibited the pathological process of NP degeneration and exerted a definite therapeutic effect on IDD. This study offers a new strategy for exploring the biological repair of IDD.

Materials and methods

Preparation of PLGA microspheres coloaded with TGF-β1 and anti-miR-141

PLGA microspheres coloaded with TGF-β1 and anti-miR-141 were prepared by the water-in-oil emulsification/solvent evaporation method [20]. First, 150 mg of PLGA was dissolved in 2 mL of dichloromethane and added to 0.2 mL of 0.5 mg TGF-β1 or anti-miR-141. The mixture was put in an ice bath and emulsified using a homogenizer (8000 rpm, 30 s). Then 0.1 mL of ammonium bicarbonate solution (100 mg/mL) was added to the system. The mixture was further emulsified using the homogenizer (4000 rpm, 30 s), and the emulsion was then added to 50 mL of polyvinyl alcohol solution, followed by homogenization (4000 rpm, 2 min). The resulting product was added to 50 mL of deionized water and magnetically stirred for more than 3 h to volatilize dichloromethane. Finally, after centrifugation (8000 rpm, 10 min), the PLGA microspheres were collected, washed with deionized water three times to remove the free non-sphered components, freeze-dried, and stored at − 20 °C for later use. The empty PLGA microspheres (Mock microsphere, MS), PLGA microspheres loaded with TGF-β1 (TMS) or anti-miR-141 alone (AMS), and PLGA microspheres coloaded with both TGF-β1 and anti-miR-141 (ATMS) were prepared in the above way.

Characterization of PLGA microspheres

The surface morphological characteristics of PLGA microspheres were observed by scanning electron microscopy under an accelerating voltage of 5 kV. The particle size of PLGA microsphere was measured using a laser particle size analyzer. To determine the distribution of TGF-β1 and anti-miR-141 in the microspheres, fluorescein-labeled PLGA microspheres were prepared and observed by laser confocal microscopy.

In vitro biomolecule release assay

The release status of TGF-β1 and anti-miR-141 from PLGA microspheres was detected at pH 7.4. First, PLGA microspheres were placed in a dialysis cassette and immersed phosphate-buffered saline (PBS) at pH 7.4 in a large beaker. A certain volume of sample was collected from the external solution chamber at predetermined intervals, and the PBS was replenished with the same volume of pH-adjusted fresh water. The level of TGF-β1 in the sample was detected by reversed-phase high-performance liquid chromatography. The presence or absence of anti-miR-141 in the sample was detected by agarose gel electrophoresis and quantified using a Quant-It™ PicoGreen dsDNA kit.

Cell proliferation assay

The spine-derived NPCs of Sprague–Dawley rats were plated in a 96-well plate (9.0 × 103/well) and cultured with Dulbecco’s modified Eagle’s medium (DMEM) in a 5% CO2 incubator at 37 °C for 24 h. Twenty microliters of 5-, 10-, 20-, and 40-d PLGA microsphere release solution were added for 24-h treatment. Then the NPCs were incubated with 20 µL of DMEM medium containing 10% Alamar blue and 10% fetal bovine serum for 2 h, and the medium was aspirated (100 µL/well). The absorbance values at 570 nm and 600 nm were measured with a microplate reader. The corresponding sample without cells was inoculated as a blank control in each group. Finally, the relative cell count was determined: cell proliferation rate = absorbanceexperimental group/absorbancecontrol group.

Apoptosis assay

The NPCs were plated in a six-well plate (2.5 × 105/well) containing 2 mL of DMEM and incubated at 37 °C overnight. After the medium was discarded, 2 mL of medium containing 100 µL of 15-d microsphere release solution was added. Twenty-four hours later, the NPCs were digested with trypsin, centrifuged, and washed twice with PBS. Then they were resuspended with binding buffer according to the kit instructions and incubated with Annexin V-FITC and PI at room temperature away from light for 10 min. Finally, apoptosis was detected by a flow cytometer (BD Biosciences, Mountain View, USA).

RT-qPCR

Total RNA was extracted from cells by TRIzol (Invitrogen, USA). The ACAN and COL2A1 mRNA expression level was measured using the SYBR® Premix Ex Taq™ II kit (Takara, Japan). The PCR program was as follows: pre-denaturation at 95 °C for 30 s, and 50 cycles of denaturation at 95 °C for 5 s and annealing/extension at 60 °C for 25 s. Relative quantification was performed by the 2Ct method, with GAPDH as an internal control. The assay was repeated three times. The primer sequences are shown in Table 1.

Table 1 Primers and sequences used in this study

Western blotting

The cell or tissue samples were collected, washed twice with PBS, and lysed with radioimmunoprecipitation assay lysis buffer for 2 h on ice, with protease inhibitors added. The lysate was centrifuged at 12,000 rpm for 10 min, and the supernatant was harvested. The proteins were quantified using a bicinchoninic acid kit. Then an equal amount of protein was separated by sodium dodecyl sulfate–polyacrylamide gel electrophoresis, and the protein of a specific molecular weight was electro-transferred onto a polyvinylidine fluoride membrane. The membrane was blocked with PBS containing 5% skim milk powder and 1% Tween-20 (PBST) at room temperature for 1 h, then incubated with primary antibodies (ACAN, COL2A1) at 4 °C overnight. After washing three times with PBST, the membrane was incubated with horseradish peroxidase–labeled secondary antibodies at room temperature for 1 h. Finally, specific protein bands were detected by chemiluminescence solution.

Immunofluorescence assay

The NPCs were fixed with 4% paraformaldehyde, permeabilized with 0.3% Triton X-100, and blocked with 2% sheep serum, followed by incubation with primary antibodies (ACAN, COL2A1) (1:1000, Abcam, USA) at 4 °C overnight. Following incubation with fluorescent secondary antibodies and DAPI, the NPCs were washed with PBS, and the change in the target protein content was observed under a laser confocal microscope (Leica, Germany).

Animal experiments

Upon the approval by the Laboratory Animal Committee of the support unit, 40 8-week-old Sprague–Dawley rats were randomly divided into a control group (Ctrl), an operation group (Mock), a TGF-β1 microsphere group (TMS), an anti-miR-141 microsphere group (AMS), and an anti-miR-141 + TGF-β1 microsphere group (ATMS), with eight rats in each group. No operation was performed in the Ctrl group. In the Mock, TMS, AMS, and ATMS groups, the rats were anesthetized with pentobarbital (40–50 mg/kg) and fixed in a supine position. After hair shaving, the abdomen was cleaned, disinfected with iodophor, and draped. Then the rat tail intervertebral disc was punctured till the central NP with a 21-G micropuncture needle (Hamilton, Bonaduz, Switzerland) under X-ray fluoroscopy. The needle was rotated 360° and then withdrawn. The puncture site was sterilized with iodophor, and 50,000 U of penicillin was injected intramuscularly to prevent infection. In the TMS, AMS, and ATMS groups, the rats were additionally injected with TMS, AMS, and ATMS in the operative intervertebral space by a 33G micropuncture needle, after which the puncture site was also sterilized with iodophor and 50,000 U of penicillin was injected intramuscularly to prevent infection. The IDD status was observed by lumbar MRI plain scan at 2 months after modeling and was evaluated by Pfirrmann grading in each group. After all rats were sacrificed, the tail intervertebral disc samples were harvested. The morphological changes in the operative segment of intervertebral disc were observed by safranin O-fast green staining. The expression of COL2A1 in the NP tissues of the operative segment was detected by immunohistochemistry and Western blotting. The intervertebral disc was stained by histologically, and the results were graded and compared according to the criteria of Masuda et al. [21].

Statistical analysis

SPSS18.0 software was used for statistical analysis. Normally distributed measurement data are described as mean ± standard deviation. The data were compared for significance using the independent-samples t-test between two groups and using one-way analysis of variance between more than two groups. Before the analysis of variance, the homogeneity test of variance was routinely performed. Tukey’s highly significant difference test was used to compare the significance of differences in the case of homogeneity of variances, while Dunnett’s T3 test was used in the case of heterogeneity of variances. P < 0.05 was considered statistically significant.

Results

Characterization of PLGA microspheres and the loading and release of biomolecules

Scanning electron microscopy showed that the PLGA microspheres had a uniform spherical shape and did not adhere to each other. The mean particle size was 100 µm (20–170 µm) (Fig. 1A, B). To directly verify the coloading of TGF-β1 and anti-miR-141 in PLGA microspheres, red TGF-β1 fluorescence and green FITC fluorescence (FITC-labeled anti-miR-141) in PLGA microspheres were observed by laser confocal microscopy. In the overlap images, PLGA microspheres displayed yellow fluorescence, suggesting that both TGF-β1 and anti-miR-141 were uniformly dispersed in the microspheres (Fig. 1C). To determine the release efficiency of TGF-β1 and anti-miR-141 from PLGA microspheres, the release solution of single-loaded and coloaded PLGA microspheres was detected for 40 consecutive days. As shown in Fig. 1D, both TGF-β1 and anti-miR-141 showed a slow release trend, and the biomolecule release rate was roughly the same between the single-loaded and coloaded PLGA microspheres. The release efficiency of TGF-β1 and anti-miR-141 reached a plateau at approximately 15 d, so the 15-d release solution of PLGA microspheres was selected for later experiments.

Fig. 1
figure 1

Characterization of PLGA microspheres and the loading and release of biomolecules. A, B SEM images of PLGA microsphere. C Localization of TGF-β1 and anti-miR-141 in microsphere. D Release detection of TGF-β1 and anti-miR-141 in vitro

Effect of PLGA microsphere release solution on NPCs

The effects of 5-, 10-, 20-, and 40-d release solution of PLGA microspheres on the proliferation of NPCs were observed. Compared with that in the MS group, the proliferation of NPCs was enhanced in the TMS, AMS, and ATMS groups, especially the ATMS group (Fig. 2A). Flow cytometry showed that the apoptosis did not differ between the MS, TMS, AMS, and ATMS groups (Fig. 2B). Furthermore, the gene and protein expression levels of cartilage markers (ACAN, COL2A1) were higher in the AMS, TMS, and ATMS groups (AMS < TMS < ATMS) compared with those in the MS group (Fig. 2C–G). The above results demonstrated that PLGA microspheres coloaded with TGF-β1 and anti-miR-141 can enhance the viability of NPCs and facilitate the protein-secreting capacity of the extracellular matrix of NPCs, and that combination of TGF-β1 and anti-miR-141 have the strongest effect.

Fig. 2
figure 2

Effect of PLGA microsphere release solution on NPCs. A Alamarblue was used to detect the proliferation level of nucleus pulposus cells under the release of PLGA microspheres at different time points. B Flow cytometry was used to detect the apoptotic level of nucleus pulposus cells under the release of PLGA microspheres in different groups. CG RT-qPCR, western blot and immunofluorescence were used to detect the expression levels of phenotypic genes and proteins of nucleus pulposus cells in different groups (n ≥ 3, *p < 0.05, **p < 0.01)

In vivo repair effect of PLGA microspheres on IDD

Whether PLGA microspheres coloaded with TGF-β1 and anti-miR-141 could promote the repair of IDD by enhancing the biological properties of NPCs was tested in the rat model of IDD established by tail puncture (Fig. 3A). MRI at 2 months after modeling showed that the intervertebral disc signal was normal in the Ctrl group, while it became significantly weakened in the Mock group due to the puncture damage, with an obvious loss of intervertebral height and the most serious degeneration among the groups. Compared with those in the Mock group, the intervertebral disc signal was only slightly decreased, with a smaller loss of intervertebral height and significantly mild degeneration, in the TMS, AMS, and ATMS groups (Fig. 3B, C).

Fig. 3
figure 3

In vivo repair effect of PLGA microspheres on IDD. A Group description of animal experiment. B, C Observation of rat tail intervertebral disc degeneration in each group by MRI and classification analysis (n ≥ 3, *p < 0.05, **p < 0.01)

Safranin O-fast green staining showed that the NP tissues of the operative segment were evenly stained red and had an intact structure in the Ctrl group. The NP tissues of the operative segment were dehydrated and disappeared in the Mock group. In the TMS, AMS, and ATMS groups, more NPCs could still be seen, and there were still many red-stained extracellular matrix components in the operative segment, especially in the ATMS group (Fig. 4A, B). Immunohistochemistry and Western blotting showed that the levels of ACAN and COL2A1 in NPCs were significantly lower in the Mock group than in the Ctrl group, while they were significantly higher in the TMS, AMS, and ATMS groups than the Mock group, especially in the ATMS group (Fig. 4C–F).

Fig. 4
figure 4

In vivo repair effect of PLGA microspheres on IDD. A, B Observation of rat tail intervertebral disc in each group by safranine and fast green staining and classification analysis. C, D The COL2A1 expression level in NP tissues in the five groups were determined by immunohistochemistry and quantitative analysis. E, F Western blot was used to detect the difference in the expression of ACAN and COL2A1 protein in nucleus pulposus tissues with different degrees of degeneration (n ≥ 3, *p < 0.05, **p < 0.01)

Discussion

Targeted delivery via microparticle systems is highly promising for the treatment of IDD [22]. First, the microparticle system can raise the chemical stability of drugs. For example, some drugs can be degraded in vivo by enzymes, such as siRNAs by RNases and proteins in the stomach by pepsin or pancreatin. This degradation can be ameliorated if the drug or the corresponding biodegradable component is loaded into a microparticle system, thereby prolonging its lifetime and increasing its efficiency. Second, the properly designed microparticle system can help improve the penetration and biodistribution of biomolecules targeting the diseased tissue. Highly biocompatible PLGA-based microspheres have been widely studied as carriers [23]. PLGA microspheres of small-molecule drugs, proteins, and plasmid DNA for in situ therapy have advantages over direct injection of drugs or gene transfection agents at the lesion site, according to previous studies on IDD [24]. Moreover, PLGA randomly aggregated by two monomers (lactic acid and glycolic acid) is a degradable functional polymer organic compound, characterized by good biocompatibility, non-toxicity, and good capsule-forming and film-forming properties [25].

The occurrence and progression of IDD result from the dysregulation of gene expression and biological factors related to various signaling pathways in NPCs. Therefore, it is necessary to promote the development of therapies combining genes and biological factors [26, 27]. Research in this field used to focus on the separate delivery of drugs or genes by different carriers, but it is difficult to deliver the biological factors and genes to the same target to exert a synergistic effect in this way. Codelivery using a properly loaded and efficiently releasing carrier has significant advantages over separate delivery [28,29,30]. The biological factors and genes coloaded can be simultaneously taken up by target cells, so that the two can exert a synergistic effect. Further work on novel codelivery systems is necessary for targeted treatment of IDD [31, 32].

TGF-β1 is a pleiotropic cytokine that can regulate proliferation, apoptosis, differentiation, inflammation, extracellular matrix synthesis, and developmental processes of NPCs [33, 34]. TGF-β1 is thought to reduce catabolism and inflammation by promoting matrix synthesis and inhibiting apoptosis, thereby facilitating chondrogenesis and protecting the intervertebral disc [35]. Mounting evidence has shown that miR-141 is a key player in the pathogenesis of IDD [36, 37]. Mechanistically, the NPC apoptosis induced by the crosstalk between miR-141 and SIRT1/NF-κB pathway is a key determinant of IDD, indicating that miR-141 is an important target for therapeutic intervention in IDD [38]. In this study, PLGA-based microspheres coloaded with TGF-β1 and anti-miR-141 were synthesized as carriers to repair the degenerated intervertebral disc by inhibiting NPC apoptosis and promoting NPC extracellular matrix synthesis. Finally, PLGA microspheres capable of codelivering TGF-β1 and anti-miR-141 were successfully prepared. The microspheres possessed good loading efficiency and a good release effect, so they stably and sustainably released TGF-β1 and anti-miR-141.

To test whether the microsphere release solution could enhance the biological functions of NPCs, the effects of single-loaded and coloaded microspheres on NPCs were compared between groups. Compared with that in the MS group, the release solution of single-loaded and coloaded microspheres enhanced the proliferation of NPCs as well as the extracellular secretion function to varying degrees, without inducing apoptosis. What is noteworthy is that the NPCs in the ATMS group displayed stronger proliferation capacity and extracellular secretion function than those in the TMS and AMS groups. This confirmed the synergistic effect of TGF-β1 and anti-miR-141 in vivo. Consistent results were obtained in the animal experiment: IDD was relieved better in the TMS, AMS, and ATMS groups than the Mock group, and the intervertebral disc in the ATMS group had the best MRI signal intensity and histological structure.

Conclusion

PLGA microspheres coloaded with TGF-β1 and anti-miR-141 can effectively suppress NPC apoptosis and facilitate NPC proliferation and matrix secretion by sustainably and stably releasing prochondrogenic growth factors and therapeutic genes, thereby relieving IDD.

Availability of data and materials

According to the requirements, data can be obtained from the corresponding author to support the results of this study.

References

  1. Zhao CQ, Wang LM, Jiang LS, Dai LY. The cell biology of intervertebral disc aging and degeneration. Ageing Res Rev. 2007;6(3):247–61.

    Article  Google Scholar 

  2. Risbud MV, Shapiro IM. Role of cytokines in intervertebral disc degeneration: pain and disc content. Nat Rev Rheumatol. 2014;10(1):44–56.

    Article  CAS  Google Scholar 

  3. Walker MH, Anderson DG. Molecular basis of intervertebral disc degeneration. Spine J. 2004;4(6 Suppl):158S-166S.

    Article  Google Scholar 

  4. Aguiar DJ, Johnson SL, Oegema TR. Notochordal cells interact with nucleus pulposus cells: regulation of proteoglycan synthesis. Exp Cell Res. 1999;246(1):129–37.

    Article  CAS  Google Scholar 

  5. Gao B, Jiang B, Xing W, Xie Z, Luo Z, Zou W. Discovery and Application of Postnatal Nucleus Pulposus Progenitors Essential for Intervertebral Disc Homeostasis and Degeneration. Adv Sci (Weinh). 2022;9(13):e2104888.

    Article  Google Scholar 

  6. Wang Y, Wang H, Zhuo Y, Hu Y, Li X, Xu Y, Sun B, Liu M, Zou L, Liu L, et al. Spheroid formation enhances the regenerative capacity of nucleus pulposus cells via regulating N-CDH and ITGbeta1 interaction. Int J Biol Sci. 2022;18(9):3676–96.

    Article  CAS  Google Scholar 

  7. Mercuri JJ, Gill SS, Simionescu DT. Novel tissue-derived biomimetic scaffold for regenerating the human nucleus pulposus. J Biomed Mater Res A. 2011;96(2):422–35.

    Article  Google Scholar 

  8. Borrelli C, Buckley CT. Injectable disc-derived ECM hydrogel functionalised with chondroitin sulfate for intervertebral disc regeneration. Acta Biomater. 2020;117:142–55.

    Article  CAS  Google Scholar 

  9. Xie J, Li B, Yao B, Zhang P, Wang L, Lu H, Song X. Transforming growth factor-beta1-regulated Fas/FasL pathway activation suppresses nucleus pulposus cell apoptosis in an inflammatory environment. Biosci Rep 2020, 40(2).

  10. Cai F, Zhu L, Wang F, Shi R, Xie XH, Hong X, Wang XH, Wu XT. The paracrine effect of degenerated disc cells on healthy human nucleus pulposus cells is mediated by MAPK and NF-kappaB pathways and can be reduced by TGF-beta1. DNA Cell Biol. 2017;36(2):143–58.

    Article  CAS  Google Scholar 

  11. Frapin L, Clouet J, Chedeville C, Moraru C, Samarut E, Henry N, Andre M, Bord E, Halgand B, Lesoeur J, et al. Controlled release of biological factors for endogenous progenitor cell migration and intervertebral disc extracellular matrix remodelling. Biomaterials. 2020;253:120107.

    Article  CAS  Google Scholar 

  12. Zhao Y, Zhang M, Li Q, Chen X. Tissue engineering material KLD-12 polypeptide/TGF-beta1 the protective effect and mechanism of nanofiber gel on early intervertebral disc degeneration. Cell Mol Biol Noisy-le-grand. 2022;68(3):282–93.

    Article  Google Scholar 

  13. Li Z, Yu X, Shen J, Chan MT, Wu WK. MicroRNA in intervertebral disc degeneration. Cell Prolif. 2015;48(3):278–83.

    Article  CAS  Google Scholar 

  14. Chen W, Chen H, Zheng D, Zhang H, Deng L, Cui W, Zhang Y, Santos HA, Shen H. Gene-hydrogel microenvironment regulates extracellular matrix metabolism balance in nucleus pulposus. Adv Sci (Weinh). 2020;7(1):1902099.

    Article  CAS  Google Scholar 

  15. Giordano L, Porta GD, Peretti GM, Maffulli N. Therapeutic potential of microRNA in tendon injuries. Br Med Bull. 2020;133(1):79–94.

    Article  CAS  Google Scholar 

  16. Oliviero A, Della Porta G, Peretti GM, Maffulli N. MicroRNA in osteoarthritis: physiopathology, diagnosis and therapeutic challenge. Br Med Bull. 2019;130(1):137–47.

    Article  CAS  Google Scholar 

  17. Gargano G, Oliviero A, Oliva F, Maffulli N. Small interfering RNAs in tendon homeostasis. Br Med Bull. 2021;138(1):58–67.

    Article  CAS  Google Scholar 

  18. Gargano G, Oliva F, Oliviero A, Maffulli N. Small interfering RNAs in the management of human rheumatoid arthritis. Br Med Bull. 2022;142(1):34–43.

    Article  Google Scholar 

  19. Athanasiou KA, Niederauer GG, Agrawal CM. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials. 1996;17(2):93–102.

    Article  CAS  Google Scholar 

  20. Liang X, Wang Y, Shi H, Dong M, Han H, Li Q. Nucleolin-Targeting AS1411 aptamer-modified micelle for the co-delivery of doxorubicin and miR-519c to improve the therapeutic efficacy in hepatocellular carcinoma treatment. Int J Nanomedicine. 2021;16:2569–84.

    Article  CAS  Google Scholar 

  21. Masuda K, Aota Y, Muehleman C, Imai Y, Okuma M, Thonar EJ, Andersson GB, An HS. A novel rabbit model of mild, reproducible disc degeneration by an anulus needle puncture: correlation between the degree of disc injury and radiological and histological appearances of disc degeneration. Spine (Phila Pa 1976). 2005;30(1):5–14.

    Article  Google Scholar 

  22. Pereira DR, Silva-Correia J, Caridade SG, Oliveira JT, Sousa RA, Salgado AJ, Oliveira JM, Mano JF, Sousa N, Reis RL. Development of gellan gum-based microparticles/hydrogel matrices for application in the intervertebral disc regeneration. Tissue Eng Part C Methods. 2011;17(10):961–72.

    Article  CAS  Google Scholar 

  23. Hodgkinson T, Stening JZ, White LJ, Shakesheff KM, Hoyland JA, Richardson SM. Microparticles for controlled growth differentiation factor 6 delivery to direct adipose stem cell-based nucleus pulposus regeneration. J Tissue Eng Regen Med. 2019;13(8):1406–17.

    Article  CAS  Google Scholar 

  24. Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 1997;28(1):5–24.

    Article  CAS  Google Scholar 

  25. Cohen S, Yoshioka T, Lucarelli M, Hwang LH, Langer R. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res. 1991;8(6):713–20.

    Article  CAS  Google Scholar 

  26. Zhang GZ, Liu MQ, Chen HW, Wu ZL, Gao YC, Ma ZJ, He XG, Kang XW. NF-kappaB signalling pathways in nucleus pulposus cell function and intervertebral disc degeneration. Cell Prolif. 2021;54(7):e13057.

    Article  CAS  Google Scholar 

  27. Li Z, Li X, Chen C, Li S, Shen J, Tse G, Chan MTV, Wu WKK. Long non-coding RNAs in nucleus pulposus cell function and intervertebral disc degeneration. Cell Prolif. 2018;51(5):e12483.

    Article  Google Scholar 

  28. Collin EC, Grad S, Zeugolis DI, Vinatier CS, Clouet JR, Guicheux JJ, Weiss P, Alini M, Pandit AS. An injectable vehicle for nucleus pulposus cell-based therapy. Biomaterials. 2011;32(11):2862–70.

    Article  CAS  Google Scholar 

  29. Liang CZ, Li H, Tao YQ, Peng LH, Gao JQ, Wu JJ, Li FC, Hua JM, Chen QX. Dual release of dexamethasone and TGF-beta3 from polymeric microspheres for stem cell matrix accumulation in a rat disc degeneration model. Acta Biomater. 2013;9(12):9423–33.

    Article  CAS  Google Scholar 

  30. Feng G, Zhang Z, Dang M, Rambhia KJ, Ma PX. Nanofibrous spongy microspheres to deliver rabbit mesenchymal stem cells and anti-miR-199a to regenerate nucleus pulposus and prevent calcification. Biomaterials. 2020;256:120213.

    Article  CAS  Google Scholar 

  31. Fontana G, See E, Pandit A. Current trends in biologics delivery to restore intervertebral disc anabolism. Adv Drug Deliv Rev. 2015;84:146–58.

    Article  CAS  Google Scholar 

  32. Liang CZ, Li H, Tao YQ, Zhou XP, Yang ZR, Xiao YX, Li FC, Han B, Chen QX. Dual delivery for stem cell differentiation using dexamethasone and bFGF in/on polymeric microspheres as a cell carrier for nucleus pulposus regeneration. J Mater Sci Mater Med. 2012;23(4):1097–107.

    Article  CAS  Google Scholar 

  33. Chen S, Liu S, Ma K, Zhao L, Lin H, Shao Z. TGF-beta signaling in intervertebral disc health and disease. Osteoarthritis Cartilage. 2019;27(8):1109–17.

    Article  CAS  Google Scholar 

  34. Zhao J, Jia L, Chen D, Xiao J, Pan X, Jing X. Adenovirus-mediated TGF-beta(1) gene transfer to human degenerative lumbar intervertebral disc cells. Chin Med J (Engl). 2002;115(3):409–12.

    CAS  Google Scholar 

  35. Zhang J, Li Z, Chen F, Liu H, Wang H, Li X, Liu X, Wang J, Zheng Z. TGF-beta1 suppresses CCL3/4 expression through the ERK signaling pathway and inhibits intervertebral disc degeneration and inflammation-related pain in a rat model. Exp Mol Med. 2017;49(9):e379.

    Article  CAS  Google Scholar 

  36. Xu J, Xie G, Yang W, Wang W, Zuo Z, Wang W. Platelet-rich plasma attenuates intervertebral disc degeneration via delivering miR-141-3p-containing exosomes. Cell Cycle. 2021;20(15):1487–99.

    Article  CAS  Google Scholar 

  37. Xu Q, Xing H, Wu J, Chen W, Zhang N. miRNA-141 induced pyroptosis in intervertebral disk degeneration by targeting ROS generation and activating TXNIP/NLRP3 signaling in nucleus pulpous cells. Front Cell Dev Biol. 2020;8:871.

    Article  Google Scholar 

  38. Ji ML, Jiang H, Zhang XJ, Shi PL, Li C, Wu H, Wu XT, Wang YT, Wang C, Lu J. Preclinical development of a microRNA-based therapy for intervertebral disc degeneration. Nat Commun. 2018;9(1):5051.

    Article  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This study was funded by The key research and development project of Anhui (Grant No. 202104b11020020).

Author information

Authors and Affiliations

Authors

Contributions

LX designed the research. DG and YZ performed the data analysis. DG and CL performed the experiments. LX wrote the manuscript. ZY edited the manuscript. All the authors read and approved the final manuscript.

Corresponding author

Correspondence to Zongsheng Yin.

Ethics declarations

Ethics approval and consent to participate

The research protocol was approved by the Ethics Committee of Yijishan Hospital of Wannan Medical College (approval number: 202026).

Consent for publication

The manuscript is approved by all authors for publication. All the authors listed have approved the manuscript that is enclosed.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Xiao, L., Gao, D., Zhang, Y. et al. Codelivery of TGF-β1 and anti-miR-141 by PLGA microspheres inhibits progression of intervertebral disc degeneration. J Orthop Surg Res 18, 17 (2023). https://doi.org/10.1186/s13018-023-03501-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13018-023-03501-5

Keywords

  • Microsphere
  • TGF-β1
  • miR-141
  • Nucleus pulposus
  • Intervertebral disc degeneration